跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ETOPOSIDE-TEVA INJECTION 20 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
ETOPOSIDE-TEVA INJECTION 20 MG/ML
Approved
THERAPEUTIC
ETOPOSIDE-TEVA INJECTION 20 MG/ML
PHARMACHEMIE BV (NETHERLANDS)
🇸🇬 Health Sciences Authority
Approval Date
Sep 29, 1998
Approval ID
8ac5c8e3432eeda2
Company
PHARMACHEMIE BV (NETHERLANDS)
Type
Therapeutic
Approval Details
Approval Id
8ac5c8e3432eeda2
Drug Name
ETOPOSIDE-TEVA INJECTION 20 MG/ML
Product Name
ETOPOSIDE-TEVA INJECTION 20 MG/ML
Approval Number
SIN10059P
Approval Date
1998-09-29
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
L01CB01
Atc Item Name
etoposide
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
ETOPOSIDE
20 mg/ml
ETOPOSIDE
20 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 29, 1998
Approval ID
8ac5c8e3432eeda2
Type
Therapeutic
Back to HSA Approvals